MENLO
PARK, Calif., Jan. 25,
2024 /PRNewswire/ -- PacBio (NASDAQ: PACB) announced
today that it will hold its quarterly conference call to discuss
its fourth quarter 2023 financial results on Thursday, February 15, 2024, at 5:00 pm Eastern Time.
The call will be webcast and may be accessed at PacBio's website
at: https://investor.pacificbiosciences.com/.
Date: Thursday, February 15, 2024,
at 5:00 pm ET (2:00 pm PT)
Listen live via internet or replay:
https://investor.pacificbiosciences.com/
Toll-free: 1-888-349-0136
International: 1-412-317-0459
If using the dial-in option, please dial into the call ten
minutes prior to start time using the appropriate number above and
ask to join the "PacBio Q4 Earnings Call."
About PacBio
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier
life science technology company that designs, develops, and
manufactures advanced sequencing solutions that enable scientists
and clinical researchers to improve their understanding of the
genome and, ultimately, resolve genetically complex problems. Our
products and technology under development stem from two highly
differentiated core technologies focused on accuracy, quality, and
completeness, which include our HiFi long-read sequencing
technology and our short-read Sequencing by Binding (SBB™)
technology. Our products address solutions across a broad set of
applications, including human genetics, plant and animal sciences,
infectious disease and microbiology, oncology, and other emerging
applications. For more information, please visit www.pacb.com and
follow @PacBio.
PacBio products are provided for research use only. Not for use
in diagnostic procedures.
Contacts
Investors:
Todd Friedman
650.521.8450
ir@pacb.com
Media:
Lizelda Lopez
pr@pacb.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/pacbio-to-report-fourth-quarter-2023-financial-results-on-february-15-2024-302045160.html
SOURCE Pacific Biosciences of California, Inc.